Mikrobiologia eta Parasitologia
Espezialitatea
Antonio
Oliver Palomo
Antonio Oliver Palomo-rekin lankidetzan egindako argitalpenak (16)
2023
-
Molecular characterization of a suspected IMP-type carbapenemase-producing Pseudomonas aeruginosa outbreak reveals two simultaneous outbreaks in a tertiary-care hospital
Infection control and hospital epidemiology, Vol. 44, Núm. 11, pp. 1801-1808
-
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis
The Lancet Regional Health - Europe, Vol. 34
-
Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 430-435
2022
-
Prevalence of the fimbrial operon mrkABCD, mrkA expression, biofilm formation and effect of biocides on biofilm formation in carbapenemase-producing Klebsiella pneumoniae isolates belonging or not belonging to high-risk clones
International Journal of Antimicrobial Agents, Vol. 60, Núm. 4
2021
-
Pseudomonas aeruginosa susceptibility in spain: Antimicrobial activity and resistance suppression evaluation by pk/pd analysis
Pharmaceutics, Vol. 13, Núm. 11
2020
-
From CLSI to EUCAST, a necessary step in Spanish laboratories
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 2, pp. 79-83
-
Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187
2018
-
Erratum for del Barrio-Tofiño et al., "Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain"
Antimicrobial agents and chemotherapy
2017
-
Genomics and susceptibility profiles of extensively drug-resistant pseudomonas aeruginosa isolates from Spain
Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 11
2016
-
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
Journal of Infection, Vol. 72, Núm. 2, pp. 152-160
2014
-
Breakpoints for carbapenemase-producing Enterobacteriaceae: Is the problem solved?
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. S4, pp. 33-40
2013
-
Epidemiological and clinical complexity of amoxicillin-clavulanate- resistant Escherichia coli
Journal of Clinical Microbiology, Vol. 51, Núm. 7, pp. 2414-2417
2012
-
Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli
Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 7, pp. 3576-3581
2009
-
Escherichia coli y Klebsiella pneumoniae productoras de betalactamasas de espectro extendido en hospitales españoles: Segundo estudio multicéntrico (proyecto GEIH-BLEE 2006)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 27, Núm. 9, pp. 503-510
2008
-
Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277
2007
-
Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)
Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229